Report Detail

Pharma & Healthcare Global Dermatology Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2938847
  • |
  • 13 February, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.

Scope of the Report:
The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.
The worldwide market for Dermatology Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Dermatology Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
External Use
Oral
Injection

Market Segment by Applications, can be divided into
Psoriasis
Skin Infections
Acne
Dermatitis
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Drug, with price, sales, revenue and global market share of Dermatology Drug in 2017 and 2018.
Chapter 3, the Dermatology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Dermatology Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Dermatology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Dermatology Drug Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 External Use
      • 1.2.2 Oral
      • 1.2.3 Injection
    • 1.3 Market Analysis by Applications
      • 1.3.1 Psoriasis
      • 1.3.2 Skin Infections
      • 1.3.3 Acne
      • 1.3.4 Dermatitis
      • 1.3.5 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 AbbVie
      • 2.1.1 Business Overview
      • 2.1.2 Dermatology Drug Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 AbbVie Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Johnson & Johnson
      • 2.2.1 Business Overview
      • 2.2.2 Dermatology Drug Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Johnson & Johnson Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Bayer
      • 2.3.1 Business Overview
      • 2.3.2 Dermatology Drug Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Bayer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Galderma
      • 2.4.1 Business Overview
      • 2.4.2 Dermatology Drug Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Galderma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Bristol-Myers Squibb
      • 2.5.1 Business Overview
      • 2.5.2 Dermatology Drug Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Novartis
      • 2.6.1 Business Overview
      • 2.6.2 Dermatology Drug Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Novartis Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Pfizer
      • 2.7.1 Business Overview
      • 2.7.2 Dermatology Drug Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Pfizer Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Merz Pharma
      • 2.8.1 Business Overview
      • 2.8.2 Dermatology Drug Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Merz Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Valeant
      • 2.9.1 Business Overview
      • 2.9.2 Dermatology Drug Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Valeant Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 LEO Pharma
      • 2.10.1 Business Overview
      • 2.10.2 Dermatology Drug Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 LEO Pharma Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 GlaxoSmithKline
      • 2.11.1 Business Overview
      • 2.11.2 Dermatology Drug Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 GlaxoSmithKline Dermatology Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Dermatology Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Dermatology Drug Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Dermatology Drug Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Dermatology Drug Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Dermatology Drug Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Dermatology Drug Market Analysis by Regions

    • 4.1 Global Dermatology Drug Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Dermatology Drug Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Dermatology Drug Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Dermatology Drug Sales and Growth Rate (2014-2019)
    • 4.3 Europe Dermatology Drug Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Dermatology Drug Sales and Growth Rate (2014-2019)
    • 4.5 South America Dermatology Drug Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Dermatology Drug Sales and Growth Rate (2014-2019)

    5 North America Dermatology Drug by Country

    • 5.1 North America Dermatology Drug Sales, Revenue and Market Share by Country
      • 5.1.1 North America Dermatology Drug Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Dermatology Drug Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Dermatology Drug Sales and Growth Rate (2014-2019)
    • 5.3 Canada Dermatology Drug Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Dermatology Drug Sales and Growth Rate (2014-2019)

    6 Europe Dermatology Drug by Country

    • 6.1 Europe Dermatology Drug Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Dermatology Drug Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Dermatology Drug Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Dermatology Drug Sales and Growth Rate (2014-2019)
    • 6.3 UK Dermatology Drug Sales and Growth Rate (2014-2019)
    • 6.4 France Dermatology Drug Sales and Growth Rate (2014-2019)
    • 6.5 Russia Dermatology Drug Sales and Growth Rate (2014-2019)
    • 6.6 Italy Dermatology Drug Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Dermatology Drug by Country

    • 7.1 Asia-Pacific Dermatology Drug Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Dermatology Drug Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Dermatology Drug Revenue and Market Share by Country (2014-2019)
    • 7.2 China Dermatology Drug Sales and Growth Rate (2014-2019)
    • 7.3 Japan Dermatology Drug Sales and Growth Rate (2014-2019)
    • 7.4 Korea Dermatology Drug Sales and Growth Rate (2014-2019)
    • 7.5 India Dermatology Drug Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Dermatology Drug Sales and Growth Rate (2014-2019)

    8 South America Dermatology Drug by Country

    • 8.1 South America Dermatology Drug Sales, Revenue and Market Share by Country
      • 8.1.1 South America Dermatology Drug Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Dermatology Drug Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Dermatology Drug Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Dermatology Drug Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Dermatology Drug Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Dermatology Drug by Countries

    • 9.1 Middle East and Africa Dermatology Drug Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Dermatology Drug Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Dermatology Drug Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Dermatology Drug Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Dermatology Drug Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Dermatology Drug Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Dermatology Drug Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Dermatology Drug Sales and Growth Rate (2014-2019)

    10 Global Dermatology Drug Market Segment by Type

    • 10.1 Global Dermatology Drug Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Dermatology Drug Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Dermatology Drug Revenue and Market Share by Type (2014-2019)
    • 10.2 External Use Sales Growth and Price
      • 10.2.1 Global External Use Sales Growth (2014-2019)
      • 10.2.2 Global External Use Price (2014-2019)
    • 10.3 Oral Sales Growth and Price
      • 10.3.1 Global Oral Sales Growth (2014-2019)
      • 10.3.2 Global Oral Price (2014-2019)
    • 10.4 Injection Sales Growth and Price
      • 10.4.1 Global Injection Sales Growth (2014-2019)
      • 10.4.2 Global Injection Price (2014-2019)

    11 Global Dermatology Drug Market Segment by Application

    • 11.1 Global Dermatology Drug Sales Market Share by Application (2014-2019)
    • 11.2 Psoriasis Sales Growth (2014-2019)
    • 11.3 Skin Infections Sales Growth (2014-2019)
    • 11.4 Acne Sales Growth (2014-2019)
    • 11.5 Dermatitis Sales Growth (2014-2019)
    • 11.6 Other Sales Growth (2014-2019)

    12 Dermatology Drug Market Forecast (2019-2024)

    • 12.1 Global Dermatology Drug Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Dermatology Drug Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Dermatology Drug Market Forecast (2019-2024)
      • 12.2.2 Europe Dermatology Drug Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Dermatology Drug Market Forecast (2019-2024)
      • 12.2.4 South America Dermatology Drug Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Dermatology Drug Market Forecast (2019-2024)
    • 12.3 Dermatology Drug Market Forecast by Type (2019-2024)
      • 12.3.1 Global Dermatology Drug Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Dermatology Drug Market Share Forecast by Type (2019-2024)
    • 12.4 Dermatology Drug Market Forecast by Application (2019-2024)
      • 12.4.1 Global Dermatology Drug Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Dermatology Drug Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Dermatology Drug . Industry analysis & Market Report on Dermatology Drug is a syndicated market report, published as Global Dermatology Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Dermatology Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,686.56
      4,029.84
      5,373.12
      3,201.60
      4,802.40
      6,403.20
      530,108.40
      795,162.60
      1,060,216.80
      292,772.40
      439,158.60
      585,544.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report